Skip to main content
NCBI home page
Annals of the Rheumatic Diseases logoLink to Annals of the Rheumatic Diseases
. 1990 Jul;49(7):557–559. doi: 10.1136/ard.49.7.557

Axillary vein thrombosis in adolescent onset systemic sclerosis.

A Leak 1, K J Patel 1, E G Tuddenham 1, J D Pearson 1, P Woo 1
PMCID: PMC1004151  PMID: 2383084

Abstract

A 16 year old girl with a two year history of systemic sclerosis developed left axillary vein thrombosis. Prolonged euglobulin clot lysis time, anti-endothelial cell antibodies, and raised von Willebrand factor antigen were shown.

Full text

PDF
557

Images in this article

558Image
on p.558
558Image
on p.558

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Awada H., Barlowatz-Meimon G., Dougados M., Maisonneuve P., Sultan Y., Amor B. Fibrinolysis abnormalities in systemic lupus erythematosus and their relation to vasculitis. J Lab Clin Med. 1988 Feb;111(2):229–236. [PubMed] [Google Scholar]
  2. Byron M. A. The clotting defect in SLE. Clin Rheum Dis. 1982 Apr;8(1):137–151. [PubMed] [Google Scholar]
  3. Furey N. L., Schmid F. R., Kwaan H. C., Friederici H. H. Arterial thrombosis in scleroderma. Br J Dermatol. 1975 Dec;93(6):683–693. doi: 10.1111/j.1365-2133.1975.tb05119.x. [DOI] [PubMed] [Google Scholar]
  4. Jarrett P. E., Morland M., Browse N. L. Treatment of Raynaud's phenomenon by fibrinolytic enhancement. Br Med J. 1978 Aug 19;2(6136):523–525. doi: 10.1136/bmj.2.6136.523. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Kahaleh M. B., Scharstein K. K., LeRoy E. C. Enhanced platelet adhesion to collagen in scleroderma. Effect of scleroderma plasma and scleroderma platelets. J Rheumatol. 1985 Jun;12(3):468–471. [PubMed] [Google Scholar]
  6. Lee P., Norman C. S., Sukenik S., Alderdice C. A. The clinical significance of coagulation abnormalities in systemic sclerosis (scleroderma). J Rheumatol. 1985 Jun;12(3):514–517. [PubMed] [Google Scholar]
  7. Nusinow S. R., Federici A. B., Zimmerman T. S., Curd J. G. Increased von Willebrand factor antigen in the plasma of patients with vasculitis. Arthritis Rheum. 1984 Dec;27(12):1405–1410. doi: 10.1002/art.1780271211. [DOI] [PubMed] [Google Scholar]
  8. Rosenbaum J., Pottinger B. E., Woo P., Black C. M., Loizou S., Byron M. A., Pearson J. D. Measurement and characterisation of circulating anti-endothelial cell IgG in connective tissue diseases. Clin Exp Immunol. 1988 Jun;72(3):450–456. [PMC free article] [PubMed] [Google Scholar]
  9. Rustin M. H., Bull H. A., Machin S. J., Isenberg D. A., Snaith M. L., Dowd P. M. Effects of the lupus anticoagulant in patients with systemic lupus erythematosus on endothelial cell prostacyclin release and procoagulant activity. J Invest Dermatol. 1988 May;90(5):744–748. doi: 10.1111/1523-1747.ep12560947. [DOI] [PubMed] [Google Scholar]
  10. Saxne T., Heinegård D., Wollheim F. A. Therapeutic effects on cartilage metabolism in arthritis as measured by release of proteoglycan structures into the synovial fluid. Ann Rheum Dis. 1986 Jun;45(6):491–497. doi: 10.1136/ard.45.6.491. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Singsen B. H. Scleroderma in childhood. Pediatr Clin North Am. 1986 Oct;33(5):1119–1139. doi: 10.1016/s0031-3955(16)36111-9. [DOI] [PubMed] [Google Scholar]

Articles from Annals of the Rheumatic Diseases are provided here courtesy of BMJ Publishing Group

RESOURCES